Hepatic Impairment Right after oral administration of only one 4 mg dose (2 mg hydromorphone rapid-launch tablets), necessarily mean exposure to hydromorphone (Cmax and AUC∞) is enhanced 4-fold in patients with average (Boy or girl-Pugh Group B) hepatic impairment in contrast with subjects wit